Joan Mackell

3.1k total citations
54 papers, 2.4k citations indexed

About

Joan Mackell is a scholar working on Psychiatry and Mental health, Pharmacology and Economics and Econometrics. According to data from OpenAlex, Joan Mackell has authored 54 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Psychiatry and Mental health, 12 papers in Pharmacology and 10 papers in Economics and Econometrics. Recurrent topics in Joan Mackell's work include Dementia and Cognitive Impairment Research (26 papers), Schizophrenia research and treatment (11 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Joan Mackell is often cited by papers focused on Dementia and Cognitive Impairment Research (26 papers), Schizophrenia research and treatment (11 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Joan Mackell collaborates with scholars based in United States, United Kingdom and Canada. Joan Mackell's co-authors include Diana D. McDonnell, Peter J. Weiden, Steven H. Ferris, Jacob Cohen, Emma Shulman, Gertrude Steinberg, Mary Mittelman, David B. Allison, John Edmeads and James M. Russell and has published in prestigious journals such as Schizophrenia Research, The Gerontologist and Psychiatric Services.

In The Last Decade

Joan Mackell

53 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joan Mackell United States	23	1.7k	569	414	374	355	54	2.4k
Peter Bentham United Kingdom	28	1.2k 0.7×	989 1.7×	455 1.1×	275 0.7×	707 2.0×	63	3.2k
Deborah B. Marin United States	31	1.2k 0.7×	870 1.5×	503 1.2×	621 1.7×	364 1.0×	73	2.9k
Rajesh Pandav United States	22	1.2k 0.7×	686 1.2×	479 1.2×	274 0.7×	147 0.4×	31	2.6k
Alan M. Mellow United States	28	1.3k 0.8×	410 0.7×	288 0.7×	305 0.8×	408 1.1×	62	3.0k
Secundino López‐Pousa Spain	35	1.8k 1.0×	697 1.2×	644 1.6×	407 1.1×	208 0.6×	103	3.9k
Armin von Gunten Switzerland	32	1.3k 0.7×	879 1.5×	288 0.7×	455 1.2×	260 0.7×	229	3.3k
Shuichi Awata Japan	34	1.2k 0.7×	935 1.6×	639 1.5×	520 1.4×	307 0.9×	180	3.8k
Jean Georges United Kingdom	22	1.1k 0.7×	514 0.9×	580 1.4×	169 0.5×	207 0.6×	52	2.3k
Burton V. Reifler United States	18	991 0.6×	396 0.7×	338 0.8×	201 0.5×	140 0.4×	52	2.2k
Sylvaine Artéro France	30	2.1k 1.2×	839 1.5×	344 0.8×	574 1.5×	209 0.6×	79	4.1k

Countries citing papers authored by Joan Mackell

Since Specialization

Citations

This map shows the geographic impact of Joan Mackell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Mackell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Mackell more than expected).

Fields of papers citing papers by Joan Mackell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Mackell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Mackell. The network helps show where Joan Mackell may publish in the future.

Co-authorship network of co-authors of Joan Mackell

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Mackell. A scholar is included among the top collaborators of Joan Mackell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Mackell. Joan Mackell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Katzman, Martin A., Andrew A. Nierenberg, Dalia Wajsbrot, et al.. (2017). Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 37(5). 555–561. 5 indexed citations

Carrasco, Josep L., Susan G. Kornstein, Roger S. McIntyre, et al.. (2016). An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder. International Clinical Psychopharmacology. 31(3). 134–146. 12 indexed citations

Sabbagh, Marwan N., Daniel D. Christensen, Rachelle S. Doody, et al.. (2013). Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer’s disease: analysis of effects of baseline features on treatment response. BMC Geriatrics. 13(1). 56–56. 22 indexed citations

Ferris, Steven H., Jeffrey L. Cummings, Daniel D. Christensen, et al.. (2013). Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity. Alzheimer s Research & Therapy. 5(1). 12–12. 12 indexed citations

Doody, Rachelle S., David Geldmacher, Martin R. Farlow, et al.. (2012). Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimer’s Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine. Dementia and Geriatric Cognitive Disorders. 33(2-3). 164–173. 33 indexed citations

Tariot, Pierre N., Steven Salloway, Jane Yardley, Joan Mackell, & Margaret Moline. (2012). Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease. BMC Research Notes. 5(1). 283–283. 18 indexed citations

Bond, John, et al.. (2010). Screening for cognitive impairment, Alzheimer's disease and other dementias: Opinions of European caregivers, payors, physicians and the general public. The journal of nutrition health & aging. 14(7). 558–562. 25 indexed citations

Jones, Roy, Sandrine Andrieu, S. Knox, & Joan Mackell. (2010). Physicians and caregivers: Ready and waiting for increased participation in clinical research. The journal of nutrition health & aging. 14(7). 563–568. 12 indexed citations

Jones, Roy, Joan Mackell, Karine Berthet, & S. Knox. (2010). Assessing attitudes and behaviours surrounding Alzheimer's disease in Europe: Key findings of the important perspectives on Alzheimer's care and treatment (IMPACT) survey. The journal of nutrition health & aging. 14(7). 525–530. 28 indexed citations

10.

Wortmann, Marc, Sandrine Andrieu, Joan Mackell, & S. Knox. (2010). Eolving attitudes to Alzheimer's disease among the general public and caregivers in Europe: Findings from the IMPACT survey. The journal of nutrition health & aging. 14(7). 531–536. 16 indexed citations

11.

Fintel, Dan J., et al.. (2007). Reduced Mortality Rates after Intensive Statin Therapy in Managed-Care Patients. Value in Health. 10(2). 161–169. 18 indexed citations

12.

Bobes, Julio, Fernando Cañas, Javier Rejas, & Joan Mackell. (2004). Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(8). 1287–1297. 29 indexed citations

13.

Allison, David B., Joan Mackell, & Diana D. McDonnell. (2003). The Impact of Weight Gain on Quality of Life Among Persons With Schizophrenia. Psychiatric Services. 54(4). 565–567. 190 indexed citations

14.

Ferris, Steven H., Joan Mackell, Richard C. Mohs, et al.. (1997). A Multicenter Evaluation of New Treatment Efficacy Instruments for Alzheimerʼs Disease Clinical Trials. Alzheimer Disease & Associated Disorders. 11. 1–12. 37 indexed citations

15.

Patterson, Marian B., James Mack, Joan Mackell, et al.. (1997). A Longitudinal Study of Behavioral Pathology Across Five Levels of Dementia Severity in Alzheimerʼs Disease. Alzheimer Disease & Associated Disorders. 11. 40–44. 42 indexed citations

16.

Schmitt, Frederick A., Christopher Ernesto, Judith Saxton, et al.. (1997). The Severe Impairment Battery. Alzheimer Disease & Associated Disorders. 11. 51–56. 126 indexed citations

17.

Mackell, Joan, Steven H. Ferris, Richard C. Mohs, et al.. (1997). Multicenter Evaluation of New Instruments for Alzheimerʼs Disease Clinical Trials. Alzheimer Disease & Associated Disorders. 11. 65–69. 13 indexed citations

18.

Sano, Mary, Joan Mackell, Marcel O. Pontón, et al.. (1997). The Spanish Instrument Protocol. Alzheimer Disease & Associated Disorders. 11. 57–64. 19 indexed citations

19.

Mittelman, Mary, Steven H. Ferris, Emma Shulman, et al.. (1995). A Comprehensive Support Program: Effect on Depression in Spouse-Caregivers of AD Patients. The Gerontologist. 35(6). 792–802. 270 indexed citations

20.

Mittelman, Mary, Steven H. Ferris, Gertrude Steinberg, et al.. (1993). An Intervention That Delays Institutionalization of Alzheimer's Disease Patients: Treatment of Spouse-Caregivers. The Gerontologist. 33(6). 730–740. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact